Kraig Biocraft Laboratories, Inc. (KBLB)
OTCMKTS · Delayed Price · Currency is USD
0.14054
+0.01154 (8.95%)
At close: Apr 15, 2026

KBLB Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-3.62-3.4-3.03-3.84-8.05
Depreciation & Amortization
0.090.090.050.080.03
Other Amortization
---1.114.7
Loss (Gain) From Sale of Assets
----0.05
Asset Writedown & Restructuring Costs
--0.1--
Loss (Gain) From Sale of Investments
-0.2----
Stock-Based Compensation
1.120.860.760.230.84
Other Operating Activities
-0.09-0.1200.030.01
Change in Inventory
-0.02--0-0.01-
Change in Accounts Payable
-0.01-0.0400.140.2
Change in Other Net Operating Assets
0.960.770.870.370.42
Operating Cash Flow
-1.79-1.84-1.24-1.89-1.8
Capital Expenditures
-0.01-0-0.01-0.01-0.1
Investment in Securities
0.44----0.45
Investing Cash Flow
0.44-0-0.01-0.01-0.55
Short-Term Debt Issued
---2.763.67
Total Debt Issued
---2.763.67
Short-Term Debt Repaid
-0.13-0.04--0.04-
Long-Term Debt Repaid
---0.06-0.06-0.05
Total Debt Repaid
-0.13-0.04-0.06-0.1-0.05
Net Debt Issued (Repaid)
-0.13-0.04-0.062.663.62
Issuance of Common Stock
2.6--0.740.27
Other Financing Activities
-0.01----
Financing Cash Flow
2.47-0.04-0.063.43.89
Net Cash Flow
1.12-1.88-1.311.511.54
Free Cash Flow
-1.79-1.84-1.25-1.89-1.9
Free Cash Flow Per Share
-0.00-0.00-0.00-0.00-0.00
Levered Free Cash Flow
-0.33-0.6-0.26-0.570.82
Unlevered Free Cash Flow
0.03-0.260.04-0.6-0.53
Change in Working Capital
0.920.730.870.50.62
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.